First Drug for Diabetic Retinopathy Approved by FDA
The Food and Drug Administration recently approved the drug Lucentis (ranibizumab) for treatment of diabetic retinopathy in patients with diabetic macular edema.
The Food and Drug Administration recently approved the drug Lucentis (ranibizumab) for treatment of diabetic retinopathy in patients with diabetic macular edema.